Thu, May 25, 2023
Sun Pharma Q4 preview: The company is expected to report a profit after tax (PAT) of Rs 1,982 crore for the January-March period against a loss of Rs 2,277 crore registered in the corresponding quarter of the preceding fiscal.
More >
Wed, May 29, 2019
Sun Pharma released its Q4FY19 performance in which the company’s net profit came in at Rs 636 crore.
Mon, May 29, 2017
Sun Pharma's fourth quarter results have been disappointing. The company said that pricing pressure in its US generic operation will continue for more time. Analysts, in the meantime, have begun downgrading the stock.
Mon, May 30, 2016
Sun Pharma is the world's fifth largest speciality generic pharmaceutical company and India's top pharmaceutical company.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
